Difference between revisions of "Corona Vaccins First Dose Efficacy"
From Tech
Jump to navigationJump to search| Line 5: | Line 5: | ||
=Moderna= |
=Moderna= |
||
[https://www.fda.gov/media/144434/download#page=28 Vaccines and Related Biological Products Advisory Committee MeetingDecember 17, 2020] |
[https://www.fda.gov/media/144434/download#page=28 Vaccines and Related Biological Products Advisory Committee MeetingDecember 17, 2020] |
||
| − | [[File: |
+ | [[File:Screenshot 2021-07-11 at 11-43-02 Vaccines and Related Biological Products Advisory Committee December 17, 2020 Meeting Bri-...-.png|frame|Cumulative Incidence Curves for the First COVID-19 Occurrence After Randomization, mITT Set] |
Revision as of 11:47, 11 July 2021
Pfizer
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Efficacy of BNT162b2 (Pfizer) against Covid-19 after the First Dose.
Moderna
Vaccines and Related Biological Products Advisory Committee MeetingDecember 17, 2020 [[File:Screenshot 2021-07-11 at 11-43-02 Vaccines and Related Biological Products Advisory Committee December 17, 2020 Meeting Bri-...-.png|frame|Cumulative Incidence Curves for the First COVID-19 Occurrence After Randomization, mITT Set]
